Recent research suggests that neuroplastic and neuroinflammatory changes may account for the mode of action of electroconvulsive therapy (ECT), although extant data do not allow for a clear disambiguation between these two hypotheses. Multimodal neuroimaging approaches (for example, combining structural and metabolic information) may help in clarifying this issue. Here we aimed to assess longitudinal changes in (i) regional gray matter (GM) volumes and (ii) hippocampal metabolite concentrations throughout an acute course of bitemporal ECT, as well as (iii) to determine the association between imaging changes and clinical improvement. We assessed 12 patients with treatment-resistant depression (TRD) at four time points (pre-treatment, after the first ECT session, after the ninth ECT session and 15 days after ECT course completion) and 10 healthy participants at two time points, 5 weeks apart. Patients with TRD showed bilateral medial temporal lobe (MTL) and perigenual anterior cingulate cortex volume increases. Left MTL volume increase was associated with (i) a hippocampal N-acetylaspartate concentration decrease, (ii) a hippocampal Glutamate+Glutamine concentration increase and (iii) significant clinical improvement. The observed findings are, in part, compatible with both neuroplastic and neuroinflammatory changes induced by ECT. We postulate that such phenomena may be interrelated, therefore reconciling the neuroplasticity and neuroinflammatory hypotheses of ECT action.
Sensory substitution devices are providing new ways for improving or replacing sensory abilities that have been lost due to disease or injury, and at the same time offer unprecedented opportunities to address how the nervous system could lead to an augmentation of its capacities. In this work we have evaluated a color-blind subject using a new visual-to-auditory sensory substitution device (SSD) device called “Eyeborg”, that allows colors to be perceived as sounds. We used a combination of neuroimaging techniques including Functional Magnetic Resonance Imaging (fMRI), Diffusion Tensor Imaging (DTI) and proton Magnetic Resonance Spectroscopy (1H-MRS) to study potential brain plasticity in this subject. Our results suggest that after 8 years of continuous use of this device there could be significant adaptive and compensatory changes within the brain. In particular, we found changes in functional neural patterns, structural connectivity and cortical topography at the visual and auditive cortex of the Eyeborg user in comparison with a control population. Although at the moment we cannot claim that the continuous use of the Eyeborg is the only reason for these findings, our results may shed further light on potential brain changes associated with the use of other SSDs. This could help to better understand how the brain adapts to several pathologies and uncover adaptive resources such as cross-modal representations. We expect that the precise understanding of these changes will have clear implications for rehabilitative training, device development and for more efficient programs for people with disabilities.